Furthermore, compared with control subjects, PD patients also exhibit high levels of tumor necrosis factor α (TNFα) in both plasma and cerebrospinal fluid [14, 15], which is accompanied with their poor cognitive performance [16, 17]. The gene discussed is TNF; the disease is Parkinson disease.